We sell ceramic filter columns for the purification and high-purity refinement of fine chemicals, including pharmaceuticals. Our columns are used from chemical and pharmaceutical research through to manufacturing, delivering approximately five times the separation performance of conventional products to improve target-compound purity. They are reusable, enabling significant cost reduction, and can be deployed immediately by simply replacing existing disposable cartridges on current equipment. From Kyoto, we provide high-performance, environmentally responsible, and cost-effective purification technology to customers worldwide.
Solaris Bio revolutionizes regenerative medicine by integrating proprietary Animal-Origin-Free (AOF) formulation designs with advanced cell protection expertise. Centered on our "Organic Solvent-Free Cryopreservation Solution," which boasts the highest safety standards, we offer comprehensive cell manufacturing solutions, including world-class growth media. Leveraging innovative R&D and quality verified by the Certificate of Material Eligibility, we simultaneously enhance cell product efficacy and reduce costs, powerfully accelerating the social implementation of next-generation healthcare.
HOIST is developing anti-cancer products with novel mechanism-of-action utilizing the MA-T® system. Further, we are pursuing epitranscriptomics drug discovery via a novel target, ALKBH. In addition, we run a drug discovery support business for our clients creating patient derived cells (PDC) / patient derived xenografts (PDX). In pharmaceutical development, HOIST aims to utilize partnerships with pharmaceutical companies (via licensing-out, joint drug discovery etc.). In the drug discovery support business, we tailor PDC/PDX solutions to individual needs of our clients, and contribute to higher success rate of product development.
A startup from UCF’s School of Medicine applying exosome technology to regenerative medicine, drug delivery, non-invasive diagnostics, and medical device development. It aims to improve quality of life through innovative healthcare solutions for intractable diseases.
The University of Osaka–developed “next-generation microfluidic PCR technology” is leveraged to deliver a rapid and easy-to-use gut microbiome testing service, and to operate a community platform business that connects people with digestive concerns with companies offering products to support gut health. We also provide contract testing services for gut microbiome analysis.
